Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

1 Jan 2004

Abstract excerpt

BACKGROUND AND OBJECTIVES: The aim of this study was to examine the cost-effectiveness of adding nucleic acid testing (NAT) to serological (antibody and antigen) screening protocols for donated blood in the United States (US) with the purpose of reducing the risks of transfusion-transmission of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). MATERIALS AND METHODS: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Hepatitis C virus research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14984557
DOI: 10.1111/j.0042-9007.2004.00379.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United StatesPMID 14984557Read ↗

Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern ChinaSemantic proximity Read ↗

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification TestingSemantic proximity Read ↗

Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.Semantic proximity Read ↗

Prevalence of human immunodeficiency virus <scp>RNA</scp> and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenariosSemantic proximity Read ↗

International review of blood donation nucleic acid amplification testingSemantic proximity Read ↗

Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithmsSemantic proximity Read ↗

Prevalence Trends of Transfusion-Transmitted Infections at a Tertiary Private Hospital Blood Bank in Uganda: A Retrospective 6-Year Review (2017 – 2022).Semantic proximity Read ↗

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity Read ↗

HEV in Blood Donors in Switzerland: The Route to Safe Blood Products.Semantic proximity Read ↗

Genomic screening for blood-borne viruses in transfusion settingsSemantic proximity Read ↗

Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisSemantic proximity Read ↗

Screening of HIV infection: role of molecular and immunological assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.